[NCEZID] Emerging Infections Program

OMB Control No: 0920-0978	ICR Reference No: 202604-0920-003
Status: Received in OIRA	Previous ICR Reference No: 202509-0920-011
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-26-0183
Title: [NCEZID] Emerging Infections Program
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 04/22/2026

	Requested	Previously Approved
Expiration Date	01/31/2029	01/31/2029
Responses	84,146	89,088
Time Burden (Hours)	38,269	40,733
Cost Burden (Dollars)	0	0

---

Abstract: The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies. This Change Request includes minor changes to instruments.

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 31204	07/14/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 47764	10/02/2025
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 31

IC Title Form No. Form Name (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report HAIC.400.1 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report ABCs Invasive Pneumococcal Disease in Children and Adults ABC 100.2 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN (aged ≥2 months to <5 years) AND ADULTS (aged ≥65 years) Active Bacterial Core Surveillance (ABCs) Case Report ABC.100.1 Active Bacterial Core Surveillance (ABCs) Case Report Active Bacterial Core Surveillance (ABCs) Neonatal Infection Expanded Tracking Form ABC 100.5 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) NEONATAL INFECTION EXPANDED TRACKING FORM Annual Survey of Laboratory Testing Practices for C. difficile Infection HAIC.400.8 Annual Survey of Laboratory Testing Practices for C. difficile Infection CANDIDEMIA CASE REPORT FORM HAIC.400.11 CANDIDEMIA CASE REPORT FORM CDC's Healthcare-Associated Infections Community Interface (HAIC) Staphylococcus aureus Laboratory Survey HAIC.400.5 CDC’s Healthcare-Associated Infections Community Interface (HAIC) Staphylococcus aureus Laboratory Survey CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT HAIC.400.7 CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT Community-Associated CP-CRE Interview HAIC.400.2 Community-Associated CP-CRE Interview Data Elements Transferred to CDC for the HAIC Death Ascertainment Project HAIC.400.13 Data Elements Transferred to CDC for the HAIC Death Ascertainment Project Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey HAIC.400.10 Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey FLUSURV-NET: CONSENT FORM FOR PATIENT/PROXY INTERVIEW (English/Spanish) FSN.300.2 FLUSURV-NET: CONSENT FORM FOR PATIENT/PROXY INTERVIEW FLUSURV-NET: PROVIDER PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM FSN.300.3 FLUSURV-NET: PROVIDER PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM FluSurv-NET Laboratory Survey FSN.300.4 FluSurv-NET Laboratory Survey FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form FSN.300.1 Influenza Hospitalizatin Surveillance Network (FluSurv-NET) Case Report Form FoodNET Lab Survey Variable List FN.200.10 FoodNET Lab Survey Variable List FoodNet Hemolytic Uremic Syndrome (HUS) FN.200.9 FoodNet CDC's FoodNet Hemolytic Uremic Syndrome (HUS) Surveillance Case Report Form FoodNet Variable List_ (CYCLOSPORA) FN.200.2 FoodNet Variable List_ (CYCLOSPORA) FoodNet Variable List_ (LISTERIA MONOCTOGENES) FN.200.3 FoodNet Variable List,_ (LISTERIA MONOCYTOGENES) FoodNet Variable List_ (SALMONELLA) FN.200.4 FoodNet Variable List_ (SALMONELLA) FoodNet Variable List_ (SHIGA TOXIN PRODUCING E.COLI) FN.200.5 FoodNet Variable List_ (SHIGA TOXIN PRODUCING E.COLI) FoodNet Variable List_ (SHIGELLA) FN.200.6 FoodNet Variable List_ (SHIGELLA) FoodNet Variable List_ (VIBRIO) FN.200.7 FoodNet Variable List_ (VIBRIO) FoodNet Variable List_ (YERSINIA) FN.200.8 FoodNet Variable List_ (YERSINIA) FoodNet Variable List_(CAMPYLOBACTER) FN.200.1 FoodNet Variable List_ (CAMPYLOBACTER) HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey HAIC.400.6 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey HAIC MuGSI KPC and NDM Treatment Collection Form HAIC.400.14 HAIC MuGSI KPC and NDM treatment collection form HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey HAIC.400.3 HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey HAIC-Surveillance Officer's Survey HAIC.400.9 HAIC Surveillance Officer’s Survey HAIC_LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE HAIC.400.12 LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report HAIC.400.4 Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	84,146	89,088	0	-4,942	0	0
Annual Time Burden (Hours)	38,269	40,733	0	-2,464	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Some of the respondents and responses were adjusted for accuracy.

---

Annual Cost to Federal Government: $41,699,051

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Kevin Joyce 404 639-1944 [email protected]

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 04/22/2026

---